DCF — MERCY SAN JUAN MEDICAL CENTER
Enterprise Value: $-157.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-157.9M
Enterprise Value
$-70.0M
PV of Cash Flows
$-87.9M
PV of Terminal Value
$-141.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $779.0M | $3.8M | 0.0% | $-29.2M | $-26.5M |
| Year 2 | $802.3M | $11.9M | 1.0% | $-22.0M | $-18.2M |
| Year 3 | $826.4M | $20.5M | 2.0% | $-14.4M | $-10.8M |
| Year 4 | $851.2M | $25.4M | 3.0% | $-11.6M | $-8.0M |
| Year 5 | $876.7M | $28.4M | 3.0% | $-10.4M | $-6.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-157.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$756.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0001407074800233367
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5